45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,915
Insurances with rates
61
CPT / HCPCS codes
9,932
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 51167-290-09 | EXAGAMGLOGENE AUTOTEMCEL 4 X 10EXP6 TO 13 X 10EXP6 CELL/ML IV SUSP | $18,480,000 | $2,640,000 | — | — | 0 |
| 71287-219-01 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $3,234,000 | $462,000 | — | — | 0 |
| 50633-210-11 | GLUCARPIDASE 1 000 UNIT INTRAVENOUS SOLUTION | $123,522 | $49,409 | — | — | 0 |
| 50474-710-81 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $107,990 | $7,199 | — | — | 0 |
| 66658-510-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $101,310 | $2,026 | — | — | 0 |
| 50881-012-10 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $78,750 | $31,500 | — | — | 0 |
| 58468-0200-1 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $73,624 | $24,541 | — | — | 0 |
| 72694-515-01 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $72,590 | $5,807 | — | — | 0 |
| 63833-518-02 | FACTOR XIII 1 000 UNIT-1 600 UNIT INTRAVENOUS SOLUTION | $55,224 | $22,090 | — | — | 0 |
| 66658-505-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $45,395 | $1,816 | — | — | 0 |
| 57894-650-01 | GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION | $43,699 | $874 | — | — | 0 |
| 0024-5823-15 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,577 | $15,031 | — | — | 0 |
| 0024-5824-11 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,577 | $15,031 | — | — | 0 |
| 51144-050-01 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $36,600 | $14,640 | — | — | 0 |
| 0173-0898-03 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $35,383 | $1,415 | — | — | 0 |
| 50881-023-11 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $34,650 | $31,500 | — | — | 0 |
| 50242-933-01 | ATEZOLIZUMAB 1 875 MG-HYALURONIDASE-TQJS 30 000 UNIT/15 ML SUBCUT SOLN | $33,755 | $900 | — | — | 0 |
| 61755-008-01 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $32,775 | $1,873 | — | — | 0 |
| 57894-503-01 | DARATUMUMAB 1 800 MG-HYALURONIDASE-FIHJ 30 000 UNIT/15 ML SUBCUT SOLN | $31,716 | $846 | — | — | 0 |
| 50242-127-01 | GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION | $31,577 | $1,263 | — | — | 0 |
| 0173-0896-01 | BELANTAMAB MAFODOTIN-BLMF 100 MG INTRAVENOUS SOLUTION | $26,479 | $10,592 | — | — | 0 |
| 50242-085-27 | ALTEPLASE BOLUS INJECTION - STEMI | $26,401 | $10,560 | — | — | 0 |
| 50242-085-25 | ALTEPLASE IV BOLUS - STROKE (DOSES >5 MG) | $26,401 | $10,560 | — | — | 0 |
| 58468-0227-1 | CAPLACIZUMAB-YHDP 11 MG SOLUTION FOR INJECTION | $25,715 | $10,286 | — | — | 0 |
| 58468-0225-1 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT | $25,715 | $10,286 | — | — | 0 |
| 50242-918-01 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $22,054 | $630 | — | — | 0 |
| 50242-087-01 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $19,150 | $7,660 | — | — | 0 |
| 73475-3041-5 | EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION | $18,571 | $371 | — | — | 0 |
| 47783-101-01 | ECALLANTIDE 10 MG/ML (1 ML) SUBCUTANEOUS SOLUTION | $17,120 | $2,283 | — | — | 0 |
| 55513-150-01 | BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION | $16,670 | $6,668 | — | — | 0 |
| 55513-160-01 | BLINATUMOMAB 35 MCG INTRAVENOUS KIT | $16,670 | $6,668 | — | — | 0 |
| 76310-022-01 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION | $16,654 | $6,662 | — | — | 0 |
| 73607-011-11 | ARTESUNATE 110 MG INTRAVENOUS SOLUTION | $16,136 | $6,454 | — | — | 0 |
| 68727-900-03 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $15,700 | $12,560 | — | — | 0 |
| 68727-900-01 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $15,700 | $12,560 | — | — | 0 |
| 50419-385-01 | COPANLISIB 60 MG INTRAVENOUS SOLUTION | $15,451 | $6,180 | — | — | 0 |
| 74725-100-64 | GALLIUM GOZETOTIDE GA 68 | $15,085 | $5,166 | — | — | 0 |
| 25010-210-27 | ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION | $15,044 | $6,018 | — | — | 0 |
| 50633-120-11 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $14,922 | $5,969 | — | — | 0 |
| 65597-801-01 | DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION | $14,673 | $5,869 | — | — | 0 |
| 50242-044-06 | ALTEPLASE IV BOLUS - STROKE (DOSES </= 5 MG) | $13,201 | $5,280 | — | — | 0 |
| 50242-044-13 | ALTEPLASE 50 MG INTRAVENOUS SOLUTION | $13,201 | $5,280 | — | — | 0 |
| 51144-030-01 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION | $12,641 | $5,056 | — | — | 0 |
| 0310-4611-50 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $12,631 | $505 | — | — | 0 |
| 50242-088-01 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $11,969 | $4,788 | — | — | 0 |
| 0143-9533-01 | ALLOPURINOL 500 MG INTRAVENOUS SOLUTION | $11,700 | $4,680 | — | — | 0 |
| 55513-032-01 | DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE | $11,610 | $4,644 | — | — | 0 |
| 57894-501-00 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION | $11,420 | $653 | — | — | 0 |
| 0006-3025-00 | BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION | $11,400 | $114 | — | — | 0 |
| 42023-157-01 | ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION | $11,400 | $4,560 | — | — | 0 |
Showing top 50 of 14,915 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.